Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Capsule networks (CapsNets), a new class of deep neural network architectures proposed recently by Hinton et al., have shown a great performance in many fields, particularly in image recognition and natural language processing. However, CapsNets have not yet been applied to drug discovery-related studies. As the first attempt, we in this investigation adopted CapsNets to develop classification models of hERG blockers/nonblockers; drugs with hERG blockade activity are thought to have a potential risk of cardiotoxicity. Two capsule network architectures were established: convolution-capsule network (Conv-CapsNet) and restricted Boltzmann machine-capsule networks (RBM-CapsNet), in which convolution and a restricted Boltzmann machine (RBM) were used as feature extractors, respectively. Two prediction models of hERG blockers/nonblockers were then developed by Conv-CapsNet and RBM-CapsNet with the Doddareddy's training set composed of 2,389 compounds. The established models showed excellent performance in an independent test set comprising 255 compounds, with prediction accuracies of 91.8 and 92.2% for Conv-CapsNet and RBM-CapsNet models, respectively. Various comparisons were also made between our models and those developed by other machine learning methods including deep belief network (DBN), convolutional neural network (CNN), multilayer perceptron (MLP), support vector machine (SVM), k-nearest neighbors (kNN), logistic regression (LR), and LightGBM, and with different training sets. All the results showed that the models by Conv-CapsNet and RBM-CapsNet are among the best classification models. Overall, the excellent performance of capsule networks achieved in this investigation highlights their potential in drug discovery-related studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adam: A Method for Stochastic Optimization
Kingma, D. P., & Ba, J. (2014) · arXiv · doi:10.48550/arxiv.1412.6980 · Cited by 98,946
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Learning representations by back-propagating errors
Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892
Context-dependent pre-trained deep neural networks for large-vocabulary speech recognition
Dahl, G. E., Yu, D., Deng, L., & Acero, A. (2012) · IEEE Transactions on Audio Speech and Language Processing · doi:10.1109/tasl.2011.2134090 · Cited by 3,011 · cited 1×
“…audio recognition, social network fi ltering, machine translation, bioinformatics, and various games (Collobert and Weston, 2008; Bengio, 2009; Dahl et al., 2012; Hinton et al., 2012; LeCun et al., 2015; Defferrard et al., 2016; Mamoshina et al., 2016), where they have produced results…”
BackgroundGenerating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Hinton, G. E., Krizhevsky, A., & Wang, S. D. (2011) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-21735-7_6 · Cited by 1,360 · cited 1×
“To reduce the internal-covariate-shift, we used batch normalization to normalize the input distribution of each layer to a standard Gaussian distribution (Hinton et al., 2011; Ioffe and Szegedy, 2015).”
MethodDeep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159 · cited 1×
“In recent years, deep learning has also been applied to drug discovery, and it has demonstrated its potentials (Lusci et al., 2013; Ma et al., 2015; Xu et al., 2015; Aliper et al., 2016; Mayr et al., 2016; Pereira et al., 2016; Subramanian et al., 2016; Kadurin et al., 2017; Ragoza et al., 2017;…”
BackgroundDeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081 · cited 1×
“…been applied to drug discovery, and it has demonstrated its potentials (Lusci et al., 2013; Ma et al., 2015; Xu et al., 2015; Aliper et al., 2016; Mayr et al., 2016; Pereira et al., 2016; Subramanian et al., 2016; Kadurin et al., 2017; Ragoza et al., 2017; Ramsundar et al., 2017; Xu et al.,…”
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Bowes, J., Brown, A. J., Hamon, J., Jarolimek, W., Sridhar, A., Waldron, G., & Whitebread, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3845 · Cited by 748 · cited 1×
“Blockade of the hERG potassium channel can result in a potentially fatal disorder called long QT syndrome, as well as serious cardiotoxicity, which has led to the withdrawal of several marketed drugs and the failure of many drug research and development projects (Fermini and Fossa, 2003; Recanatini et al., 2005; Sangu…”
BackgroundApplications of Deep Learning in Biomedicine
Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701
Cited by
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
A review on the recent applications of deep learning in predictive drug toxicological studies
Sinha, K., Ghosh, N., & Sil, P. C. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00375 · Cited by 64
Blockchain-Federated-Learning and Deep Learning Models for COVID-19 Detection Using CT Imaging
Kumar, R., Khan, A. A., Kumar, J., Zakria, Golilarz, N. A., Zhang, S., Ting, Y., Zheng, C., & Wang, W. (2021) · IEEE Sensors Journal · doi:10.1109/jsen.2021.3076767 · Cited by 57
“Moreover, we use the Lanczos interpolation [27] to resale the standard resolutions.”
Method
Metadata
- Authors
- Wang, Y., Huang, L., Jiang, S., Wang, Y., Zou, J., Fu, H., & Yang, S.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-01-28
- Volume
- 10
- Pages
- 1631-1631
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3003259175
- Cited by
- 64
- References
- 16
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers. https://app.cochat.ai/papers/10.3389/fphar.2019.01631
- The paper
- Wang, Y., Huang, L., Jiang, S., Wang, Y., Zou, J., Fu, H., & Yang, S. (2020). Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.01631
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.